INMD
InMode Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$14.91
+0.47%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 374.6M | 370.5M | 394.8M | 492.0M | 454.3M |
| Cost of Revenue | 87.9M | 79.5M | 77.8M | 80.7M | 73.5M |
| Gross Profit | 286.7M | 291.0M | 317.1M | 411.3M | 380.8M |
| Operating Expenses | |||||
| R&D Expense | 14.3M | 13.3M | 13.1M | 13.4M | 12.4M |
| SG&A Expense | 203.2M | 192.3M | 191.4M | 202.3M | 170.5M |
| General & Admin Expense | 16.1M | 11.7M | 10.0M | 9.2M | 9.9M |
| Selling & Marketing Expense | 187.1M | 180.6M | 181.4M | 193.0M | 160.6M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 217.5M | 205.6M | 204.5M | 215.7M | 182.9M |
| Cost and Expenses | 305.4M | 285.1M | 282.3M | 296.4M | 256.4M |
| Operating Income (EBIT) | 69.2M | 85.4M | 112.5M | 195.7M | 197.9M |
| Non-Operating | |||||
| Interest Income | 21.8M | 24.9M | 30.9M | 21.6M | 3.6M |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 21.8M | 24.9M | 30.9M | 21.6M | 3.6M |
| Other Non-Op Income/Expense | 21.8M | 24.9M | 30.9M | 21.6M | 3.6M |
| Non-Operating Income (excl Interest) | (14.3M) | (24.9M) | (30.9M) | (21.6M) | (3.6M) |
| EBT (Pre-Tax Income) | 91.0M | 110.3M | 143.5M | 217.3M | 201.5M |
| Income Tax Expense | 13.4M | 16.5M | (37.8M) | 19.3M | 39.9M |
| Bottom Line | |||||
| Net Income | 77.5M | 93.8M | 181.3M | 197.9M | 161.5M |
| Earnings from Cont. Ops | 77.5M | 93.8M | 181.3M | 197.9M | 161.5M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 77.5M | 93.8M | 181.3M | 197.9M | 161.5M |
| Per Share | |||||
| Basic EPS | $1.25 | $1.45 | $2.29 | $2.37 | $1.96 |
| Diluted EPS | $1.23 | $1.43 | $2.25 | $2.30 | $1.89 |
| Revenue Per Share | $6.36 | $5.73 | $4.98 | $5.89 | $5.51 |
| Shares | |||||
| Basic Shares Outstanding | 58.9M | 64.6M | 79.3M | 83.5M | 82.5M |
| Diluted Shares Outstanding | 59.4M | 65.4M | 80.6M | 86.0M | 85.4M |
| Profitability Metrics | |||||
| EBITDA | 84.2M | 111.0M | 144.2M | 217.9M | 202.1M |
| D&A | 684.0K | 695.0K | 728.0K | 623.0K | 680.0K |
| EBIT | 83.5M | 110.3M | 143.5M | 217.3M | 201.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026